eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
11.40
+0.95 (9.09%)
Apr 9, 2026, 4:00 PM EDT - Market closed
eXoZymes Employees
eXoZymes had 31 employees as of December 31, 2024. The number of employees increased by 2 or 6.90% compared to the previous year.
Employees
31
Change (1Y)
2
Growth (1Y)
6.90%
Revenue / Employee
n/a
Profits / Employee
-$295,443
Market Cap
96.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adicet Bio | 102 |
| Fractyl Health | 101 |
| Fortress Biotech | 101 |
| XBiotech | 85 |
| BeyondSpring | 44 |
| Cognition Therapeutics | 28 |
| Gain Therapeutics | 25 |
| Cingulate | 14 |
EXOZ News
- 9 days ago - eXoZymes Provides Fourth Quarter and Full Year 2025 Update - Accesswire
- 15 days ago - eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026 - Accesswire
- 22 days ago - Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability - Accesswire
- 4 weeks ago - eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium - Accesswire
- 2 months ago - With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation - Accesswire
- 2 months ago - eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - Accesswire
- 4 months ago - eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion - Accesswire
- 5 months ago - eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today - Accesswire